Cybin (HELP) Depreciation & Amortization (CF) (2020 - 2025)

Cybin (HELP) posted quarterly Depreciation & Amortization (CF) of $22000.0 for Q4 2025, down 76.72% year-on-year from $94492.1 in Q4 2024, and down 24.14% on a QoQ basis from $29000.0 in Q3 2025.

Cybin (HELP) Depreciation & Amortization (CF) (2020 - 2025) Analysis & Trends

Cybin (HELP) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $22000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 76.72% year-over-year to $22000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $89000.0 (down 70.35% YoY) and the FY2023 annual result came in at $36915.1, up 125.73% from the prior year.
  • Depreciation & Amortization (CF) slipped to $22000.0 in Q4 2025 per HELP's latest filing, from $29000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for HELP reached as high as $104826.6 in Q3 2024 and fell as low as -$56037.0 in Q1 2023.
  • A 5-year average of $44053.1 and a median of $38000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) soared 250.06% — and 2023, when it sank 1051.88%.
  • Year by year, Depreciation & Amortization (CF) stood at $34906.8 in 2021, then surged by 49.84% to $52305.9 in 2022, then surged by 99.41% to $104304.0 in 2023, then dropped by 9.41% to $94492.1 in 2024, then tumbled by 76.72% to $22000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $22000.0, $29000.0, and $38000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Cybin 28.04 Mn 28.04 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 22,000.00
Dec 31, 2025 22,000.00
Sep 30, 2025 29,000.00
Sep 30, 2025 29,000.00
Jun 30, 2025 38,000.00
Jun 30, 2025 38,000.00
Dec 31, 2024 94,492.09
Dec 31, 2024 94,492.09
Sep 30, 2024 104,826.64
Sep 30, 2024 104,826.64
Jun 30, 2024 100,897.40
Jun 30, 2024 100,897.40
Dec 31, 2023 104,304.04
Dec 31, 2023 104,304.04
Sep 30, 2023 52,961.06
Sep 30, 2023 52,961.06
Jun 30, 2023 51,367.22
Jun 30, 2023 51,367.22
Feb 28, 2023 -56,036.99
Feb 28, 2023 -56,036.99